1Kunrtzke JF. Rating neurologic impairrment in multiple sclerosis: an expanded disabtlity status scale (EDSS) [J]. Neurology, 1983,33(11):1444-1452.
2Visser LH, Beekman R, Tijssen CC, et al. A randomized, doubleblind, placebo-controlled pilot study of i. v. immuneglobulins in combination with i. v. methyperednisolone in the treatment of relapses in patients with MS[J]. Multscler, 2004,10(1):89-91.
3Gayo A, Mozo L, Suarez A, et al. Glucocoreoids increase IL-10 expression in multiple scelrosis patients with acute relapses [J]. J Neuroimmunol, 1998,85(2):122-130.
4Schmidt J,Gold R,Schonrock L, et al. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methyprednisolone pulse therapy[J] .Brain,2000,123(Pt 7):1431-1441.
5Leussink VI, Jung S, Merschdorf U, et al. High-dose methyprednisolone therapy in multiple sclerisis induces apoptosis in peripheral blood leukocvtes[J]. Arch Neuriol, 2001,58(1):91-97.
6Karussis DM, Vourka-karussis U, Lehmann D. Prevetion and reversal of adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoveductive treatment foilwed by syngeneic bone marrow transplation [J]. Clin Inrest, 1993,92(2):765-772.
7Saiz A, Carreras E, Berenguer J, et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS [J].Neurology.2001,56(8):1084-1089.
8Tran EH, Hardin-Pouzet H, Verge G, etal. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis [J]. J Neuroimmunol, 1997,74(1-2):121-129.
10Kalyvas A, David S. Cytosolic phospholipase A2 plays a key role in the 4 pathogenesis of multiple sclerosis-like disease [J]. Neuron, 2004,1(3):323-325.
